| Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects (NCT02109835) | British Cardiac Research Trust | 2012-09-01 |
| High Intensity Interval Training (HIT) in Patients With Type 2 Diabetes (NCT01732705) | University of Copenhagen | 2012-09-01 |
| SoLaHmo Radio Stories About Children's Healthy Eating and Exercise (NCT02135328) | University of Minnesota | 2012-09-01 |
| The VALIDATE-D Study (NCT01635062) | Brigham and Women's Hospital | 2012-09-01 |
| Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)Study (NCT01665989) | Massachusetts General Hospital | 2012-08-01 |
| the Effect of Vitamin D on the Serum Thioredoxin, TBP-2, Thioredoxin Reductase, Gene Expression of TBP-2 in Patients With Type II Diabetes (NCT01876563) | Tehran University of Medical Sciences | 2012-08-01 |
| The Microvascular Function of GLP-1 and Its Analogues (NCT01677104) | Katarina Kos | 2012-08-01 |
| Customer Support Response Study (NCT01547403) | VeraLight, Inc. | 2012-08-01 |
| Diabetes Outcomes and Nurse Case Manager Study (NCT01659294) | BCDiabetes.Ca | 2012-08-01 |
| FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (NCT01524705) | University of Washington | 2012-08-01 |
| Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin (NCT01628445) | University of Manitoba | 2012-08-01 |
| Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes (NCT01499108) | Peter Rossing | 2012-08-01 |
| High Protein Breakfast on Postprandial Glycemia in T2D (PBD) (NCT02854202) | Hospital de Clinicas Caracas | 2012-08-01 |
| Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism (NCT02721888) | Centre Hospitalier Universitaire Dijon | 2012-07-10 |
| Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes (NCT01664624) | AstraZeneca | 2012-07-01 |
| Effects of Dark Chocolate on Exercise Capacity, and Mitochondrial Structure and Function (NCT01671514) | University of California, San Diego | 2012-07-01 |
| Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp" (NCT01660386) | Shanghai Jiao Tong University School of Medicine | 2012-07-01 |
| Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes (NCT01647308) | Ionis Pharmaceuticals, Inc. | 2012-07-01 |
| Effect of Breakfast or Omission of Breakfast in T2D (NCT01571310) | Tel Aviv University | 2012-07-01 |
| Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes (NCT01606007) | AstraZeneca | 2012-07-01 |
| A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) (NCT01621178) | Eli Lilly and Company | 2012-07-01 |
| Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus (NCT01642108) | Niigata Medical Center | 2012-07-01 |
| Type 2 Diabetes and Exercise Function in Single Leg Exercises (NCT01793909) | University of Colorado, Denver | 2012-06-01 |
| Liraglutide and Cardio-Metabolic Risk Markers (NCT01715428) | University of Palermo | 2012-06-01 |
| Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes (NCT01619059) | AstraZeneca | 2012-06-01 |
| Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans (NCT01660009) | Medical College of Wisconsin | 2012-06-01 |
| Evaluation of SCOUT DS Device in the Diagnosis of Diabetes (NCT01634997) | VeraLight, Inc. | 2012-06-01 |
| Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease (NCT01609582) | Takeda | 2012-06-01 |
| Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding (NCT01597531) | East Carolina University | 2012-06-01 |
| Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 Diabetes (NCT01688778) | Bispebjerg Hospital | 2012-06-01 |
| Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes (NCT01984489) | Jiangsu HengRui Medicine Co., Ltd. | 2012-06-01 |
| A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes (NCT01624259) | Eli Lilly and Company | 2012-06-01 |
| The Effect of Dietary Nitrate Supplementation on Ability of Individuals With Type 2 Diabetes to Perform Exercise (NCT02206074) | University of Exeter | 2012-05-01 |
| A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes (NCT01965509) | Jiangsu HengRui Medicine Co., Ltd. | 2012-05-01 |
| Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus (NCT01663220) | Foundation for the National Institutes of Health | 2012-05-01 |
| Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes (NCT01663207) | Foundation for the National Institutes of Health | 2012-05-01 |
| Resveratrol and Type 2 Diabetes (NCT01638780) | Maastricht University Medical Center | 2012-05-01 |
| Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy (NCT01805830) | Handok Inc. | 2012-05-01 |
| Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients (NCT01620125) | Vastra Gotaland Region | 2012-05-01 |
| Weight Loss Study for People With Type 2 Diabetes (NCT01601574) | Medical University of South Carolina | 2012-05-01 |
| Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant (NCT01593215) | Anders Rosengren, MD PhD | 2012-05-01 |
| Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes (NCT01836796) | Vastra Gotaland Region | 2012-05-01 |
| A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes (NCT01593137) | Fundación Fernández-Cruz | 2012-05-01 |
| The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects (NCT01579981) | Hvidovre University Hospital | 2012-04-01 |
| Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes (NCT01576328) | Mesoblast, Ltd. | 2012-04-01 |
| Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China (NCT01525693) | China Cardiometabolic Registries | 2012-04-01 |
| Behavioral Economics Incentives for Health Management (NCT01823458) | University of Southern California | 2012-04-01 |
| Barriers to Physical Activity in People With Type 2 Diabetes (NCT01701570) | University of Colorado, Denver | 2012-04-01 |
| Bias Source of Signal in SCOUT DS (NCT01550328) | VeraLight, Inc. | 2012-04-01 |
| Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment (NCT02236962) | Bayside Health | 2012-04-01 |
| Incretins and Metabolism (NCT01607944) | Rigshospitalet, Denmark | 2012-04-01 |
| A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes (NCT01607294) | Esperion Therapeutics, Inc. | 2012-04-01 |
| REMEDIES4D: REdesigning MEDication Intensification Effectiveness Study for Diabetes (NCT01611168) | University of Pittsburgh | 2012-04-01 |
| Lifestyle Improvement Through Food and Exercise (LIFE)Study (NCT01901952) | Rush University Medical Center | 2012-03-01 |
| Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes (NCT01586442) | Montreal Heart Institute | 2012-03-01 |
| The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes (NCT02143440) | RenJi Hospital | 2012-03-01 |
| A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes (NCT01965496) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus (NCT01689051) | University Hospital, Gentofte, Copenhagen | 2012-03-01 |
| Step Monitoring to Improve ARTERial Health (NCT01475201) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2012-02-01 |
| Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes (NCT01528059) | feng Zheng | 2012-02-01 |
| CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target (NCT01548222) | Diabetes Care Center | 2012-02-01 |
| Electronically Connected Health Coaching in Type 2 Diabetes (NCT02036892) | York University | 2012-02-01 |
| Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION) (NCT01541956) | Novartis Pharmaceuticals | 2012-02-01 |
| A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus (NCT01574365) | Kyowa Kirin Co., Ltd. | 2012-02-01 |
| Exercise, Heart Failure, and Type 2 Diabetes (NCT02122835) | Duke University | 2012-02-01 |
| UCSD Take Charge Study (NCT01345500) | University of California, San Diego | 2012-02-01 |
| Effects of Neuro-myo-electrical Stimulation on Insulin Sensitivity in Patients With Type 2 Diabetes (NCT02510521) | University Hospital, Caen | 2012-02-01 |
| A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus (NCT01572610) | Kyowa Kirin Co., Ltd. | 2012-02-01 |
| A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes (NCT01500798) | Biogen | 2012-01-31 |
| Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications (NCT01518101) | Novartis Pharmaceuticals | 2012-01-01 |
| Effects of Pinitol on Hidrocarbonated Metabolism Parameters in Diabetic, Impaired and Normal Fasting Glucose Subjects (NCT01754792) | University of Valencia | 2012-01-01 |
| Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes (NCT01886989) | Arpita Basu | 2012-01-01 |
| Effects of DPP-4 Inhibition on Triglycerides (NCT01527747) | Oregon Health and Science University | 2012-01-01 |
| Postprandial Insulin Secretion, Oxidative Stress and Gastrointestinal Peptides in Patients With Type 2 Diabetes Versus Healthy Subjects (NCT01572402) | Institute for Clinical and Experimental Medicine | 2012-01-01 |
| Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus (NCT02046395) | Tulane University School of Medicine | 2012-01-01 |
| Mindfulness: a Novel Approach for the Management of Diabetes-related Distress (NCT01805245) | University of North Carolina, Chapel Hill | 2012-01-01 |
| The Effects of Micronutrients in Combination With Usual Care in Type 2 Diabetes (NCT01738802) | Walter Reed National Military Medical Center | 2012-01-01 |
| Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients (NCT01687582) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2012-01-01 |
| Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake (NCT01232946) | Indiana University | 2012-01-01 |
| Pantoprazole on Insulin Secretion in Diabetes (NCT01541735) | Coordinación de Investigación en Salud, Mexico | 2012-01-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects (NCT01551381) | Evolva SA | 2012-01-01 |
| Arterial Wall Calcium Load in Pseudoxanthoma Elasticum (NCT01731080) | University Hospital, Angers | 2012-01-01 |
| Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER) (NCT01440660) | Association for Innovation and Biomedical Research on Light and Image | 2012-01-01 |
| Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone (NCT01257412) | AstraZeneca | 2012-01-01 |
| Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk (NCT01727349) | Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | 2011-12-14 |
| A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes (NCT01511900) | Catabasis Pharmaceuticals | 2011-12-01 |
| Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes (NCT02180646) | University of Missouri-Columbia | 2011-12-01 |
| Effects of Food Cooking on Diabetes-2 Risk Factors (NCT01617304) | University of Copenhagen | 2011-12-01 |
| The Effect of GLP-1 on the Inhibition of Glucagon Secretion (NCT01507597) | University Hospital, Gentofte, Copenhagen | 2011-12-01 |
| Role of Interleukin-1 in the Regulation of Muscle Derived Interleukin-6 During Exercise (NCT01771445) | Marc Y.Donath | 2011-12-01 |
| The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics (NCT01478776) | Tehran University of Medical Sciences | 2011-12-01 |
| Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin (NCT01757587) | Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | 2011-12-01 |
| Smoking Cessation Intervention for Diabetic Patients (NCT01501877) | Rhode Island Hospital | 2011-12-01 |
| Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes (NCT01492283) | University Hospital, Gentofte, Copenhagen | 2011-12-01 |
| Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes (NCT01494298) | Mercer University | 2011-12-01 |
| Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy (NCT01574508) | Shanghai Jiao Tong University School of Medicine | 2011-12-01 |
| Sitagliptin in Prevention of Type 2 Diabetes Mellitus (NCT01038648) | India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | 2011-12-01 |
| Skills for Change: Nutrition Education Program for Emirati Adults With Type 2 Diabetes (NCT04264793) | United Arab Emirates University | 2011-11-20 |
| Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion (NCT02749032) | Michael A. Nauck | 2011-11-01 |
| Peer Support for Achieving Independence in Diabetes (NCT02152852) | Public Health - Seattle and King County | 2011-11-01 |